These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17892353)

  • 1. Biomarker validation: movement towards personalized medicine.
    Zhang X
    Expert Rev Mol Diagn; 2007 Sep; 7(5):469-71. PubMed ID: 17892353
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and validation of new biomarkers: major opportunities for health-care scientists.
    Sturgeon C; Selby P
    Ann Clin Biochem; 2010 Nov; 47(Pt 6):499-502. PubMed ID: 21057049
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA.
    Zhang J; Lang HP; Huber F; Bietsch A; Grange W; Certa U; McKendry R; Güntherodt HJ; Hegner M; Gerber Ch
    Nat Nanotechnol; 2006 Dec; 1(3):214-20. PubMed ID: 18654189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarrays: emerging standard for biomarker validation.
    Hassan S; Ferrario C; Mamo A; Basik M
    Curr Opin Biotechnol; 2008 Feb; 19(1):19-25. PubMed ID: 18053705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GENERAL AND PERSONALIZED APPROACH OF BIOMARKERS].
    Cavalier E
    Rev Med Liege; 2015; 70(5-6):257-61. PubMed ID: 26285449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward personalized medicine for age-related macular degeneration.
    Moroi SE; Heckenlively JR
    Ophthalmology; 2008 Jun; 115(6):925-6. PubMed ID: 18519068
    [No Abstract]   [Full Text] [Related]  

  • 9. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
    VanMeter A; Signore M; Pierobon M; Espina V; Liotta LA; Petricoin EF
    Expert Rev Mol Diagn; 2007 Sep; 7(5):625-33. PubMed ID: 17892368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.
    Tomida S; Takeuchi T; Shimada Y; Arima C; Matsuo K; Mitsudomi T; Yatabe Y; Takahashi T
    J Clin Oncol; 2009 Jun; 27(17):2793-9. PubMed ID: 19414676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry.
    Tanaka K; Tsugawa N; Kim YO; Sanuki N; Takeda U; Lee LJ
    Biochem Biophys Res Commun; 2009 Jan; 379(1):110-4. PubMed ID: 19073144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ex vivo systems for biomarker discovery.
    Lavallie ER; Dorner AJ; Burczynski ME
    Curr Opin Pharmacol; 2008 Oct; 8(5):647-53. PubMed ID: 18771752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fast modified protocol for random-access ultra-high density whole-genome scan: a tool for personalized genomic medicine, positional mapping, and cytogenetic analysis.
    Lau KC; Mak CM; Leung KY; Tsoi TH; Tang HY; Lee P; Lam CW
    Clin Chim Acta; 2009 Aug; 406(1-2):31-5. PubMed ID: 19445911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis.
    Lee JW; Hall M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1259-71. PubMed ID: 19038585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis guarded: the crisis in American primary care medicine.
    Wulfers M
    Mo Med; 2008; 105(6):471, 473-4. PubMed ID: 19052006
    [No Abstract]   [Full Text] [Related]  

  • 16. Microarrays--chances and challenges.
    Pilarsky CP; Schmitt AO; Dahl E; Rosenthal A
    Curr Opin Mol Ther; 1999 Dec; 1(6):727-36. PubMed ID: 19629870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Would you prefer multiple reaction monitoring or antibodies with your biomarker validation?
    Issaq HJ; Veenstra TD
    Expert Rev Proteomics; 2008 Dec; 5(6):761-3. PubMed ID: 19086854
    [No Abstract]   [Full Text] [Related]  

  • 18. Alignment of LC-MS images, with applications to biomarker discovery and protein identification.
    Vandenbogaert M; Li-Thiao-Té S; Kaltenbach HM; Zhang R; Aittokallio T; Schwikowski B
    Proteomics; 2008 Feb; 8(4):650-72. PubMed ID: 18297649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalised medicine in primary care.
    Nichols JA
    Br J Gen Pract; 2004 Feb; 54(499):138. PubMed ID: 15046062
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative proteomics for drug toxicity.
    Gao Y; Holland RD; Yu LR
    Brief Funct Genomic Proteomic; 2009 Mar; 8(2):158-66. PubMed ID: 19351682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.